Top Pharmaceuticals stocks in North America
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $779.66bn | 74.01 | 0.57% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $352.99bn | 15.73 | 3.25% |
MRKMerck & Co | $317.97bn | 23.65 | 2.39% |
ABBVAbbvie | $284.73bn | 31.86 | 3.71% |
AMGNAmgen | $164.07bn | 43.44 | 2.82% |
PFEPfizer | $162.40bn | 10.22 | 5.76% |
CELG RTBristol-Myers Squibb Co | $83.29bn | 0.01 | 4610.78% |
BMYBristol-Myers Squibb Co | $83.29bn | 10.96 | 5.62% |
GILDGilead Sciences | $80.07bn | 11.45 | 4.7% |
ZTSZoetis | $77.37bn | 32.36 | 0.92% |
MCKMcKesson | $74.04bn | 25.38 | 0.41% |
BIIBBiogen | $32.75bn | 24.32 | n/a |
HZNPHorizon Therapeutics | $26.63bn | 51.44 | n/a |
CAHCardinal Health | $24.18bn | 18.78 | 2.01% |
RPRXRoyalty Pharma | $16.38bn | 15.38 | 2.96% |
BMRNBiomarin Pharmaceutical | $14.25bn | 71.13 | n/a |
INCYIncyte | $12.98bn | 17.12 | n/a |
VTRSViatris | $12.62bn | 21.22 | 4.53% |
CTLTCatalent | $9.73bn | n/a | n/a |